12-Oxa-2,3,7,10-tetraazatridecanoic acid, 9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-,(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester, (5S,6S,9S)-

≥95%

Reagent Code: #222010
label
Alias (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl (5S,6S,9S)-9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-12-oxa-2,3,7,10-tetraazatridecanoate
fingerprint
CAS Number 1003871-04-2

science Other reagents with same CAS 1003871-04-2

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 707.79 g/mol
Formula C₃₇H₄₆FN₅O₈
inventory_2 Storage & Handling
Density 1.31±0.1 g/cm3(Predicted)
Storage Room temperature

description Product Description

Used as an intermediate in the synthesis of complex pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports high selectivity in binding to enzyme active sites, making it valuable in antiviral drug research, especially for HIV and related viral infections. The compound’s stereochemistry and functional groups enable precise molecular interactions, enhancing drug efficacy and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties in new therapeutic agents.

Available Sizes & Pricing

Size Availability Unit Price Quantity
1mg
10-20 days ฿24,680.00
5mg
10-20 days ฿59,380.00
12-Oxa-2,3,7,10-tetraazatridecanoic acid, 9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-,(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester, (5S,6S,9S)-
No image available

Used as an intermediate in the synthesis of complex pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports high selectivity in binding to enzyme active sites, making it valuable in antiviral drug research, especially for HIV and related viral infections. The compound’s stereochemistry and functional groups enable precise molecular interactions, enhancing drug efficacy and metabolic stability. It is also employed in structure-activity relationship (SAR) st

Used as an intermediate in the synthesis of complex pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports high selectivity in binding to enzyme active sites, making it valuable in antiviral drug research, especially for HIV and related viral infections. The compound’s stereochemistry and functional groups enable precise molecular interactions, enhancing drug efficacy and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties in new therapeutic agents.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...